Cargando…
Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries
We observed substantial differences in predicted Major Histocompatibility Complex II (MHCII) epitope presentation of SARS-CoV-2 proteins for different populations but only minor differences in predicted MHCI epitope presentation. A comparison of this predicted epitope MHC-coverage revealed for the e...
Autores principales: | Liang, Chunguang, Bencurova, Elena, Psota, Eric, Neurgaonkar, Priya, Prelog, Martina, Scheller, Carsten, Dandekar, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961590/ https://www.ncbi.nlm.nih.gov/pubmed/33807854 http://dx.doi.org/10.3390/ijms22052630 |
Ejemplares similares
-
Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes
por: Jørgensen, Kasper Winther, et al.
Publicado: (2010) -
HLA-DO as the Optimizer of Epitope Selection for MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013) -
Endogenous Antigen Presentation of MHC Class II Epitopes through Non-Autophagic Pathways
por: Leung, Carol S. K.
Publicado: (2015) -
Organizing MHC Class II Presentation
por: Fooksman, David R.
Publicado: (2014) -
MHC Class II Presentation in Autoimmunity
por: Ishina, Irina A., et al.
Publicado: (2023)